---
title: "Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference | EDSA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286920055.md"
description: "Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference | EDSA Stock News"
datetime: "2026-05-19T05:15:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286920055.md)
  - [en](https://longbridge.com/en/news/286920055.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286920055.md)
---

# Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference | EDSA Stock News

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference | EDSA Stock News

### Related Stocks

- [EDSA.US](https://longbridge.com/en/quote/EDSA.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)
- [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)